Role of CTLA Inhibition in Management of Non-Small Cell Lung Cancer

By
Justin.choi
-
0
30
The authors review the current role for CTLA-4 inhibitors in early-stage resectable NSCLC, unresectable stage III NSCLC, and in metastatic NSCLC.
[Current Oncology Reports]
Abstract